David Weild - Apr 20, 2023 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Role
Director
Signature
/s/ Kenneth L. Londoner, attorney-in-fact
Stock symbol
BSGM
Transactions as of
Apr 20, 2023
Transactions value $
$0
Form type
4
Date filed
4/21/2023, 04:33 PM
Previous filing
Feb 28, 2023
Next filing
Aug 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSGM Common Stock Award $0 +17.5K +21.54% $0.00 99K Apr 20, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of restricted stock were granted in lieu of remuneration for the Company's 2023 first quarter board fees and shall be fully vested as of April 20, 2023, the date of the grant, based on a closing price of $1.32 per share on such date.